These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3349230)

  • 21. Role of neutrophils in gastric damage induced by platelet activating factor.
    Etienne A; Thonier F; Hecquet F; Braquet P
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):422-5. PubMed ID: 3244384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric mucosal damage induced in rats by intravenous administration of platelet-activating factor.
    Binnaka T; Yamaguchi T; Hirohara J; Hiramatsu A; Mizuno T; Sameshima Y
    Scand J Gastroenterol Suppl; 1989; 162():67-70. PubMed ID: 2595311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist.
    Handley DA; Van Valen RG; Melden MK; Flury S; Lee ML; Saunders RN
    Immunopharmacology; 1986 Aug; 12(1):11-6. PubMed ID: 3019921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric damage following local intra-arterial administration of reactive oxygen metabolites in the rat.
    Esplugues JV; Whittle BJ
    Br J Pharmacol; 1989 Aug; 97(4):1085-92. PubMed ID: 2551438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog.
    Handley DA; Van Valen RG; Tomesch JC; Melden MK; Jaffe JM; Ballard FH; Saunders RN
    Immunopharmacology; 1987 Apr; 13(2):125-32. PubMed ID: 3597060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc acexamate reduces gastric damage induced by platelet-activating factor.
    Escolar G; Navarro C; Galmés JL; Casanovas LI; Bulbena O
    Prostaglandins Leukot Essent Fatty Acids; 1989 Oct; 38(1):49-53. PubMed ID: 2608701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet activating factor induced gastric damage in rats: participation of increased gastric vascular permeability.
    Hatakeyama K; Yano S; Watanabe K
    Scand J Gastroenterol Suppl; 1989; 162():71-4. PubMed ID: 2595312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential antagonism of platelet activating factor-induced neutrophilia and gastric hemorrhage in the rat.
    Thomas TK; Chesonis RS; Schmolze D; Symington J; Harbison ML; Walser A; Will PC
    Agents Actions; 1993; 39 Spec No():C195-7. PubMed ID: 8273566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage.
    Brambilla A; Ghiorzi A; Giachetti A
    Pharmacol Res Commun; 1987 Feb; 19(2):147-51. PubMed ID: 3588650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.
    Wu MS; Biftu T; Doebber TW
    J Pharmacol Exp Ther; 1986 Dec; 239(3):841-5. PubMed ID: 3795043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endogenous platelet-activating factor (PAF) in endotoxin-induced portal hypertension in rats.
    Kitagawa S; Kubota Y; Yamaguchi T; Fujimura K; Binnaka T; Tani K; Ogura M; Mizuno T; Inoue K
    J Gastroenterol Hepatol; 1992; 7(5):481-5. PubMed ID: 1391729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanosensitive properties of gastric vagal afferent fibers in the rat.
    Ozaki N; Sengupta JN; Gebhart GF
    J Neurophysiol; 1999 Nov; 82(5):2210-20. PubMed ID: 10561400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent ulcerogenic actions of platelet-activating factor on the stomach.
    Rosam AC; Wallace JL; Whittle BJ
    Nature; 1986 Jan 2-8; 319(6048):54-6. PubMed ID: 3510396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW; Wu MS; Biftu T
    J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CNS effects of platelet-activating factor on the rat stomach.
    Cucala M; Wallace JL; Salas A; Guarner F; Rodríguez R; Malagelada JR
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():67-71. PubMed ID: 2725123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes.
    Wallace JL; MacNaughton WK
    Eur J Pharmacol; 1988 Jun; 151(1):43-50. PubMed ID: 2843390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial heterogeneity of mucosal blood flow during ischemia-reperfusion injury of rat stomach investigated by laser Doppler perfusion imaging.
    Miura S; Fukumura D; Kurose I; Kimura H; Suzuki M; Morishita T; Nagata H; Tsuchiya M; Ishii H
    J Gastroenterol; 1995 Jun; 30(3):279-86. PubMed ID: 7647892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of neuropeptide Y and noradrenaline on rat gastric mucosal blood flow and integrity.
    Tepperman BL; Whittle BJ
    Br J Pharmacol; 1991 Jan; 102(1):95-100. PubMed ID: 2043936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.